Technology - Monoclonal Antibody, Anti Ft LVS LpnA/Tu14 Clone 164

Monoclonal Antibody, Anti Ft LVS LpnA/Tu14 Clone 164

An intracellular bacterium that can initiate the human response to Tularemia

Background:

Francisella tularensis is an intracellular, gram-negative bacterium that invades macrophages and initiates the human immune response.

Technology Overview:

Tularemia, commonly known as ?rabbit fever? can be communicated across several species including; rabbits, rodents and humans. The murine monoclonal antibody recognizes a native epitope of Francisella tularensis ?Live Vaccine Strain?; IgG monoclonal antibody clone 164 against a native epitope of Francisella tularensis protein, LpnA/Tu14.
Source: Gavin Allanwood, unsplash.com/photos/hcxqLJjI99E, Unsplash Licence

Advantages:

The antibody was developed from a mouse infected with F.tularensis live vaccine strain and not recombinant protein, therefore representing a natural antibody made by the mouse in defence of infection against the native F. tularensis protein.

Applications:

Western blot - ELISA - Immunoprecipitation - Immunofluorescence assays

Intellectual Property Summary:

 

Stage of Development:

 

Licensing Status:

Available for license.

Licensing Potential:

Licensing

Additional Information:

Patent Information: